MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, BTAI made $98K in revenue. -$30,911K in net income. Net profit margin of -31541.84%.

Income Overview

Revenue
$98K
Net Income
-$30,911K
Net Profit Margin
-31541.84%
EPS
-$2.18
Unit: Thousand (K) dollars

Income Statement
2025-09-30
2025-06-30
2025-03-31
2024-12-31
Product revenue, net
98 120 168 289*
Cost of goods sold
11 107 14 295*
Research and development
8,740 10,256 4,554 10,735*
Selling, general and administrative
5,381 5,609 5,699 8,793*
Restructuring costs
194 0 --1,172*
Total operating expenses
14,326 15,972 10,267 18,650*
Loss from operations
-14,228 -15,852 -10,099 -18,361*
Interest expense
4,373 4,222 3,993 3,894*
Interest income
236 230 279 672*
Other (income) expense, net
-12,546 657 6,559 -5,091*
Net loss
-30,911 -19,187 -7,254 -26,675
Basic EPS
-2.18 -2.45 -1.5 0.355
Diluted EPS
-2.18 -2.45 -1.5 0.355
Basic Average Shares
14,196,000 7,843,000 4,834,000 -75,038,000
Diluted Average Shares
14,196,000 7,843,000 4,834,000 -75,038,000
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net loss-$30,911K (-126.45%↓ Y/Y)Interest income$236K (-61.69%↓ Y/Y)Loss from operations-$14,228K (6.96%↑ Y/Y)Other (income)expense, net-$12,546K (-360.45%↓ Y/Y)Interest expense$4,373K (15.38%↑ Y/Y)Product revenue, net$98K (-54.21%↓ Y/Y)Total operatingexpenses$14,326K (-7.62%↓ Y/Y)Research and development$8,740K (71.34%↑ Y/Y)Selling, general andadministrative$5,381K (-29.96%↓ Y/Y)Restructuring costs$194K (-87.51%↓ Y/Y)Cost of goods sold$11K (-99.06%↓ Y/Y)

BioXcel Therapeutics, Inc. (BTAI)

BioXcel Therapeutics, Inc. (BTAI)